Shaun Hawkins
Fortune : 15 559 $ au 31/05/2026
Fortune : 15 559 $ au 31/05/2026
Shaun Hawkins is the founder of Prosytec SAS. Currently, Mr. Hawkins is Director at ImmuneWorks, Inc. and Independent Director at Invesque, Inc. since 2016.
Formerly, Mr. Hawkins was Chairman at Muroplex Therapeutics, Inc. and Audion Therapeutics BV, Director at Zymeworks BC, Inc., Accelerator Services Corp, and Zymeworks, Inc., Vice President-New Ventures at Eli Lilly Canada, Inc. from 2012 to 2015, and Managing Partner at Pier 70 Ventures LLC.
Mr. Hawkins completed undergraduate studies at the University of Tennessee in 1995 and earned an MBA from Kellogg School of Management in 2000.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INVESQUE INC 0,02 % | 06/05/2026 | 155 591 ( 0,02 % ) | 15 559 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INVESQUE INC. | Directeur/Membre du Conseil | 05/04/2016 |
ImmuneWorks, Inc.
ImmuneWorks, Inc. Pharmaceuticals: MajorHealth Technology Develops autoimmune lung disease treatment | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Corporate Officer/Principal | 01/01/2015 |
| ZYMEWORKS INC. | Directeur/Membre du Conseil | - |
Prosytec SAS
Prosytec SAS Industrial MachineryProducer Manufacturing Provides sealants for the construction and window assembly markets | Fondateur | - |
Pier 70 Ventures
Pier 70 Ventures Investment ManagersFinance Pier 70 Ventures invests in companies located in the United States. The firm focuses on digital health, med tech, diagnostics and health services sectors. It participates in early-stage capital requirements with an investment size of USD 0.25 to 2 million. The firm makes follow-on investments amounting from USD 2 to 5 million. | Corporate Officer/Principal | - |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 12 |
|---|---|
ImmuneWorks, Inc.
ImmuneWorks, Inc. Pharmaceuticals: MajorHealth Technology Develops autoimmune lung disease treatment | Health Technology |
Muroplex Therapeutics, Inc.
Muroplex Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Audion Therapeutics BV
Audion Therapeutics BV Pharmaceuticals: MajorHealth Technology Discovers and deveops of drugs | Health Technology |
Eli Lilly Canada, Inc.
Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Prosytec SAS
Prosytec SAS Industrial MachineryProducer Manufacturing Provides sealants for the construction and window assembly markets | Producer Manufacturing |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invesque, Inc.
Invesque, Inc. Real Estate Investment TrustsFinance Operates as health care real estate company that invests medial office buildings | Finance |
Pier 70 Ventures
Pier 70 Ventures Investment ManagersFinance Pier 70 Ventures invests in companies located in the United States. The firm focuses on digital health, med tech, diagnostics and health services sectors. It participates in early-stage capital requirements with an investment size of USD 0.25 to 2 million. The firm makes follow-on investments amounting from USD 2 to 5 million. | Finance |
Zymeworks, Inc.
Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national